Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01804530
Title Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Plexxikon
Indications

Advanced Solid Tumor

pancreatic adenocarcinoma

Therapies

PLX7486

Gemcitabine + Nab-paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.